Clindamycin-BPO 2.5% gel was compared with the individual active ingredients (clindamycin phosphate 1.2% and BPO 2.5%) and vehicle over 12 weeks.
benzoyl peroxide (BPO). But how does it compare to a 2-drug combination (BPO/adapalene gel, clindamycin/adapalene gel, or clindamycin/BPO gel)?
But how does it compare to a 2-drug combination (BPO/adapalene gel, clindamycin/adapalene gel, or clindamycin/BPO gel)? The dosing is 25 mg
Clindamycin-BPO 2.5% gel was compared with the individual active ingredients (clindamycin phosphate 1.2% and BPO 2.5%) and vehicle over 12 weeks. Clindamycin
Clindamycin-BPO 2.5% gel was compared with the individual active ingredients (clindamycin phosphate 1.2% and BPO 2.5%) and vehicle over 12 weeks. Clindamycin-
benzoyl peroxide (BPO). But how does it compare to a 2-drug combination (BPO/adapalene gel, clindamycin/adapalene gel, or clindamycin/BPO gel)?
Clindamycin-BPO 2.5% gel was compared with the individual active ingredients (clindamycin phosphate 1.2% and BPO 2.5%) and vehicle over 12 weeks. Clindamycin-
what's in the pipeline. But how does it compare to a 2-drug combination (BPO/adapalene gel, clindamycin/adapalene gel, or clindamycin/BPO gel)?
A/BPO Clindamycin/BPO (2 weeks, once daily) 72: Mean scores for erythema, dryness, and peeling were significantly higher with A/BPO than with clindamycin/BPO. Patients rated clindamycin/BPO gel more tolerable than A/BPO: A/BPO clindamycin/BPO: C: Gollnick et al6: Multicenter, open-label, prospective noninterventional observational cohort study
Comments